Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT01839747
This research study is a Pilot study (a small preliminary study to assess the feasibility of a larger, more in depth study involving a new test or procedure) and is being done to evaluate the feasibility and accuracy of PET/MRI in the evaluation of cancer. PET/MRI is a FDA approved technology that is currently being studied to assess its accuracy and utility in the diagnosis and management of a variety of diseases and patient populations. The focus of this particular study will be to compare the performance of PET/MRI in its ability to detect and characterize cancerous tumors using positron emission topography and computed tomography (PET/CT) as a reference standard.
Looking for future studies?
Notify Me5 year–18 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
If you agree to participate in this study you will be asked to fill out a screening questionnaire to determine if you can participate. No additional screening tests or procedures will be necessary prior to your participation in this study.
If the screening questionnaire shows that you are eligible to participate in the research study, you will be scheduled to undergo your PET/MRI in conjunction with your PET/CT. If you do not meet the eligibility criteria, you will not be able to participate in this research study.
After th screening procedures confirm that you are eligible to participate in the research study:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Imaging
Imaging
Time frame: 2 years
To perform a qualitative comparison of image quality between PET-MRI and PET-CT exams being performed on pediatric oncology patients during the same visit
Time frame: 2 years
To compare the ability of PET-MRI to determine the extent of active malignancy by comparing PET-MRI SUV values with PET-CT FDG reference
Time frame: 2 years
To assess the number of unexpected indeterminate lesions detected on PET-MRI and PET-CT studies requiring additional workup
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04690205
Hematologic Diseases, Hematologic Malignancy
Boston, Massachusetts, United States
View Trial DetailsNCT06415656
Hematologic Diseases, Hematologic Malignancy
Durham, North Carolina, United States
View Trial DetailsNCT05397132
Hematologic Diseases, Hematologic Malignancy
Durham, North Carolina, United States
View Trial DetailsNCT05715047
Hematologic Cancer, Hematologic Diseases
Boston, Massachusetts, United States
View Trial Details